BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9820056)

  • 1. [The effect of ramipril on metabolic, renal and cardiac function in hypertension and type II diabetes mellitus].
    Vítovec J; Spinar J
    Vnitr Lek; 1998 Jun; 44(6):336-41. PubMed ID: 9820056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The nephroprotective effect of ramipril. Effect on blood pressure and metabolic control in insulin-treated patients with type-2 diabetes mellitus].
    Jungmann E; Krüger K; Semler B; Haak T; Scherberich J; Schumm-Draeger PM; Usadel KH
    Fortschr Med; 1994 Jan; 112(3):39-42. PubMed ID: 8144124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ramipril in the treatment of hypertension. The pharmacodynamic validation of its efficacy in the therapy of initial cardiac and renal involvement].
    Ivleva AIa; Moiseev VS; Antiia ID
    Ter Arkh; 1993; 65(4):52-8. PubMed ID: 8059408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The metabolic effects of isradipine, ramipril, Ednit and beta-adrenoblockers in patients with non-insulin-dependent diabetes mellitus and arterial hypertension].
    Morugova TV; Lazareva DN
    Eksp Klin Farmakol; 1999; 62(2):39-42. PubMed ID: 10340128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
    Linz W; Schäfer S; Afkham F; Gerl M; Schmidts HL; Rütten H
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
    Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G
    Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
    Steinman TI
    Nephrol Dial Transplant; 2008 Feb; 23(2):431-3. PubMed ID: 18065782
    [No Abstract]   [Full Text] [Related]  

  • 16. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys].
    MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
    Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
    Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An AT-II blocker in patients with type II diabetes and arterial hypertension].
    Ametov AS; Demidova TIu; Kosykh SA
    Klin Med (Mosk); 2006; 84(2):50-5. PubMed ID: 16613007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.